表紙
市場調查報告書

腎交感神經阻斷術設備市場 - 成長率,趨勢,及預測(2019年 - 2024年)

Renal Denervation Devices Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 871444
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
Back to Top
腎交感神經阻斷術設備市場 - 成長率,趨勢,及預測(2019年 - 2024年) Renal Denervation Devices Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年05月01日內容資訊: 英文 114 Pages
簡介

腎交感神經阻斷術設備市場成長的主要原因,是高血壓的罹患率上升和該治療的長期影響。

本報告提供腎交感神經阻斷術設備市場的相關調查,市場概況和成長要素、阻礙因素,各技術、各地區的市場分析,競爭情形,主要企業的簡介等資訊的彙整

目錄

第1章 簡介

  • 研究成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 高血壓的罹患率上升
    • 治療效果的持續性
  • 市場阻礙因素
    • 疼痛伴隨的治療
    • 嚴格的核准流程
  • 波特五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業的競爭

第5章 市場區隔

  • 各科技
    • 高頻為基礎
    • 超音波為基礎
    • 微輸液為基礎
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott
    • Ablative Solutions
    • Boston Scientific Corporation
    • CardioSonic
    • Kona Medical
    • Medtronic Plc
    • Mercator MedSystems
    • ReCor Medical
    • Symple Surgical

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 57103

Market Overview

The major factors for the growth of the renal denervation devices market include the rising prevalence of hypertension and the long-lasting effect of the procedure.

High blood pressure is called hypertension. The prevalence of hypertension has observed a significant rise over the past few years. Generally, blood pressure rises and falls throughout the day, but it can damage one's heart and result in health problems if hypertension stays high for a long time. According to the CDC (Centers for Disease Control and Prevention), about 75 million American adults (32%) have high blood pressure (hypertension), but only about half (54%) of them with high blood pressure have their condition under control. High blood pressure was a primary and contributing cause of death for more than 410,000 Americans, in 2014. CDC also states that high blood pressure costs the nation USD 48.6 billion every year. The high prevalence is not just limited to the United States, owing to the fact that Europe and South Asian countries also have a high rate of hypertension makes this a global problem. On the other hand, only a few renal denervation devices are approved in Europe, while the major players are gaining approval for the clinical trials from the FDA in the United States. Thus, owing to the all above-mentioned factors the market is expected to witness high growth in the next coming years.

Scope of the Report

As per the scope of this report, renal denervation devices are one of several innovative device-based interventional therapies, which helps to control blood pressure. It is safe, minimally invasive, and it does not leave any implants behind. The market is segmented by technology and geography.

Key Market Trends

Ultrasound-Based is the Segment by Technology is expected to be the Fastest Growing Segment

The ultrasound-based renal denervation devices is a minimally invasive procedure using ultrasound to ablate nerves in the wall of the renal arteries and it disrupts the transmission of nerve impulses to and from the kidney and lowers blood pressure. Furthermore, according to the first randomized trial to compare the techniques (RADIO SOUND-HTN trial), the ultrasound-based renal denervation (RDN) approach led to greater reductions in the blood pressure than radiofrequency ablation in patients with resistant hypertension. The rising prevalence of hypertension is expected to boost the overall growth of the market.

Europe is Expected to Dominate the Market

Europe is found to hold a major share for the renal denervation devices market and is expected to show a similar trend over the forecast period, without significant fluctuations. According to the data published by Public Health England, high blood pressure affects more than 1 in 4 adults in England. There is a number of renal denervation devices who have received CE approval in Europe. The major factor driving the growth of the market is rising R&D activities for the development of efficient devices. As per the clinicaltrials.gov, one of the market player Abbott Medical Devices has completed the observational study of the EnligHTN renal denervation system in Europe in February 2019. Furthermore, rising cases of drug-resistant hypertension will boost the overall growth of the market over the forecast period.

Competitive Landscape

The market studied is a consolidated market owing to the presence of the few major market players. Some of the market players are Abbott, Ablative Solutions, Boston Scientific Corporation, CardioSonic, Kona Medical, Medtronic Plc, Mercator MedSystems, ReCor Medical, and Symple Surgical

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Hypertension
    • 4.2.2 Long Lasting Effect of the Procedure
  • 4.3 Market Restraints
    • 4.3.1 Painful procedure
    • 4.3.2 Stringent Approval Process for Renal Denervation Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Radiofrequency Based
    • 5.1.2 Ultrasound Based
    • 5.1.3 Micro-Infusion Based
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 US
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 UK
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Ablative Solutions
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 CardioSonic
    • 6.1.5 Kona Medical
    • 6.1.6 Medtronic Plc
    • 6.1.7 Mercator MedSystems
    • 6.1.8 ReCor Medical
    • 6.1.9 Symple Surgical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top